These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 2331742)

  • 1. [Determination of the oxidation phenotype in the Czechoslovak population using metoprolol].
    Ulc I; Ulc J; Cepeláková H
    Cas Lek Cesk; 1990 Feb; 129(8):244-6. PubMed ID: 2331742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphism of dextromethorphan oxidation in Polish population.
    Skretkowicz J; Wojtczak A; Rychlik-Sych M
    Acta Pol Pharm; 2008; 65(5):611-5. PubMed ID: 19051610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of CYP2D6 genotype on adverse effects during treatment with metoprolol: a prospective clinical study.
    Fux R; Mörike K; Pröhmer AM; Delabar U; Schwab M; Schaeffeler E; Lorenz G; Gleiter CH; Eichelbaum M; Kivistö KT
    Clin Pharmacol Ther; 2005 Oct; 78(4):378-87. PubMed ID: 16198657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased frequency of cytochrome P450 2D6 poor metabolizers among patients with metoprolol-associated adverse effects.
    Wuttke H; Rau T; Heide R; Bergmann K; Böhm M; Weil J; Werner D; Eschenhagen T
    Clin Pharmacol Ther; 2002 Oct; 72(4):429-37. PubMed ID: 12386645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Debrisoquine and metoprolol oxidation in Zambians: a population study.
    Simooya OO; Njunju E; Hodjegan AR; Lennard MS; Tucker GT
    Pharmacogenetics; 1993 Aug; 3(4):205-8. PubMed ID: 8220440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assay of metoprolol and alpha-hydroxymetoprolol in human urine by reversed-phase liquid chromatography with direct-injection.
    Xie HG; Zhou HH
    Zhongguo Yao Li Xue Bao; 1995 Jan; 16(1):32-5. PubMed ID: 7771192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant interaction between the nonprescription antihistamine diphenhydramine and the CYP2D6 substrate metoprolol in healthy men with high or low CYP2D6 activity.
    Hamelin BA; Bouayad A; Méthot J; Jobin J; Desgagnés P; Poirier P; Allaire J; Dumesnil J; Turgeon J
    Clin Pharmacol Ther; 2000 May; 67(5):466-77. PubMed ID: 10824625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphic metabolism of metoprolol: clinical studies.
    Silas JH; McGourty JC; Lennard MS; Tucker GT; Woods HF
    Eur J Clin Pharmacol; 1985; 28 Suppl():85-8. PubMed ID: 4054194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous determination of metoprolol and alpha-hydroxymetoprolol in human plasma and urine by liquid chromatography with a preliminary observation on metoprolol oxidation in Japanese subjects.
    Horai Y; Ishizaki T; Kusaka M; Tsujimoto G; Hashimoto K
    Ther Drug Monit; 1988; 10(4):428-33. PubMed ID: 3201527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of dextromethorphan metabolic phenotype by salivary analysis with a reference to genotype in Chinese patients receiving renal hemodialysis.
    Hou ZY; Chen CP; Yang WC; Lai MD; Buchert ET; Chung HM; Pickle LW; Woosley RL
    Clin Pharmacol Ther; 1996 Apr; 59(4):411-7. PubMed ID: 8612385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of dextromethorphan after single or multiple dosing in combination with quinidine in extensive and poor metabolizers.
    Pope LE; Khalil MH; Berg JE; Stiles M; Yakatan GJ; Sellers EM
    J Clin Pharmacol; 2004 Oct; 44(10):1132-42. PubMed ID: 15342614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that serine 304 is not a key ligand-binding residue in the active site of cytochrome P450 2D6.
    Ellis SW; Hayhurst GP; Lightfoot T; Smith G; Harlow J; Rowland-Yeo K; Larsson C; Mahling J; Lim CK; Wolf CR; Blackburn MG; Lennard MS; Tucker GT
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):565-71. PubMed ID: 10642515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metoprolol oxidation polymorphism in Brazilian elderly cardiac patients.
    Neves DV; Lanchote VL; de Souza L; Hayashida M; Nogueira MS; de Moraes NV; Cesarino EJ
    J Pharm Pharmacol; 2013 Sep; 65(9):1347-53. PubMed ID: 23927473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative phenotype status in related subjects.
    Rychlik-Sych M; Łyczba M; Skretkowicz J
    Acta Pol Pharm; 2008; 65(1):165-8. PubMed ID: 18536192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism of dextromethorphan oxidation in South Indian subjects.
    Mamidi RN; Satyavageeswaran S; Vakkalanka SV; Chaluvadi MR; Katneni K; Brahmadevara N; Damodarram G; Subramaniam S
    Clin Pharmacol Ther; 1999 Aug; 66(2):193-200. PubMed ID: 10460073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metoprolol and mephenytoin oxidation polymorphisms in Far Eastern Oriental subjects: Japanese versus mainland Chinese.
    Horai Y; Nakano M; Ishizaki T; Ishikawa K; Zhou HH; Zhou BI; Liao CL; Zhang LM
    Clin Pharmacol Ther; 1989 Aug; 46(2):198-207. PubMed ID: 2758729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of input rate on the stereospecific and nonstereospecific first pass metabolism and pharmacokinetics of metoprolol extended release formulations.
    Mistry B; Leslie JL; Eddington ND
    Chirality; 2002 May; 14(4):297-304. PubMed ID: 11968069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of CYP2D6 polymorphism and quinidine on the disposition and antitussive effect of dextromethorphan in humans.
    Capon DA; Bochner F; Kerry N; Mikus G; Danz C; Somogyi AA
    Clin Pharmacol Ther; 1996 Sep; 60(3):295-307. PubMed ID: 8841152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme polymorphism on the metabolic O-demethylation of dextromethorphan in a South American population.
    Estévez F; Giusti M; Parrillo S; Oxandabarat J
    Medicina (B Aires); 1996; 56(4):378-82. PubMed ID: 9138342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phenotypes of oxidation and acetylation in Alzheimer's disease--preliminary report].
    Milejski P; Orzechowska-Juzwenko K; Niewiński P; Hurkacz M; Czarnik-Matusewicz H; Leszek J; Rudzik J; Grotthus B
    Psychiatr Pol; 2007; 41(2):261-9. PubMed ID: 17598435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.